加拿大丰业银行美股招股说明书(2026-04-14版)

PRODUCT SUPPLEMENT NO. WF-2(To Prospectus dated November 8, 2024 and Prospectus Supplement dated November 8, 2024) The Bank of Nova ScotiaSenior Note Program, Series ANotes Linked To One Or More Indices, Exchange-Traded Funds or Equity Securities The Bank of Nova Scotia may, from time to time, offer and sell notes linked to one or more equity indices (each, an “Index” and collectively,the “Indices”), exchange-traded funds (each, a “Fund” and collectively, the “Funds”) or common equity securities or American depositaryshares (“ADSs”) of a company not affiliated with us (each, an “Underlying Stock” and collectively, the “Underlying Stocks”), or anycombination thereof. The Indices, Funds and Underlying Stocks are sometimes referred to herein collectively as the “Market Measures” andindividually as a “Market Measure.” The notes provide for the repayment of principal at maturity regardless of the performance of the relevantMarket Measure(s) (subject to issuer credit risk), as well as the potential for a positive return based on the performance of the relevant MarketMeasure(s). We refer to all notes offered under this product supplement as the “notes.” The notes will be senior unsecured debt securities of The Bank of Nova Scotia (the “Bank”). Any payments due on the notes, including anyrepayment of principal, will be subject to credit risk of the Bank. If the Bank were to default on its obligations, you could lose some or all ofyour investment. This prospectus supplement, which we refer to as a “product supplement,” describes some of the general terms that apply to the notes. Thisproduct supplement supplements the disclosure in any pricing supplement that may reference it, the accompanying prospectus, prospectussupplement and other accompanying supplement. A separate pricing supplement will describe terms that apply to specific issuances of thenotes and may include changes to the terms specified in this product supplement. If the disclosure in the relevant pricing supplement isinconsistent with the disclosure in this product supplement or the accompanying prospectus or prospectus supplement or any otheraccompanying supplement, the disclosure in the relevant pricing supplement will control. You should carefully review the specific terms of the notes described in the applicable pricing supplement together with the informationcontained in this product supplement, the accompanying prospectus and prospectus supplement and any other accompanying supplementbefore investing in the notes. The notes will not be listed on any securities exchange or automated quotation system. Scotia Capital (USA) Inc. (“SCUSA”) and Wells Fargo Securities, LLC (“WFS”) will be the agents for the distribution of the notes (the“Agents”). See “Supplemental Plan of Distribution (Conflicts of Interest)” herein. The calculation agent will be Scotia Capital Inc., an affiliateof the Bank. The notes have complex features and investing in the notes involves risks not associated with an investment in conventional debtsecurities. See “Risk Factors” beginning on page PS-3 of this product supplement. In addition, see the applicable pricing supplement,which will describe more specifically the risks relating to the particular issuance of notes as well as the risks associated with theparticular Market Measure(s) to which your notes are linked. The notes are not insured by the Canada Deposit Insurance Corporation pursuant to the Canada Deposit Insurance Corporation Act(the “CDIC Act”) or the U.S. Federal Deposit Insurance Corporation or any other governmental agency of Canada, the United Statesor any other jurisdiction. Neither the Securities and Exchange Commission (the “SEC”) nor any state securities commission or other regulatory body hasapproved or disapproved of these notes or passed upon the accuracy or adequacy of this product supplement or the accompanyingprospectus supplement and prospectus. Any representation to the contrary is a criminal offense. TABLE OF CONTENTS About This Product SupplementSummaryRisk FactorsGeneral Terms of the NotesBenefit Plan Investor ConsiderationsMaterial U.S. Federal Income Tax ConsequencesSupplemental Discussion of Canadian Tax ConsiderationsSupplemental Plan of Distribution (Conflicts of Interest)Use of Proceeds and Hedging ABOUT THIS PRODUCT SUPPLEMENT You should read this product supplement, together with the accompanying prospectus and prospectus supplement and any other accompanyingsupplement, the applicable pricing supplement and/or other supplement, which together contain a description of the terms of the notes to beoffered, and which supersede all prior or contemporaneous oral statements as well as any other written materials. You should carefully consider, among other things, the matters set forth under “Risk Factors” in this product supplement and the applicablepricing supplement, as the notes have complex features and involve risks not associated with conventional debt securities. We urge you toc